Pharmacology, Toxicology and Pharmaceutical Science
Alanine Aminotransferase
5%
Amoxicillin
6%
Anticoagulant Agent
51%
Antidiabetic Agent
5%
Antiinfective Agent
47%
Antiulcer Agent
8%
Atrial Fibrillation
47%
Cannabis
47%
Cerebrovascular Accident
6%
Clavulanic Acid
6%
Clinical Pharmacy
47%
Clinical Pharmacy
23%
Clinical Trial
95%
Cognitive Defect
7%
Cohort Study
9%
Coronavirinae
9%
COVID-19 Vaccine
9%
Cross Sectional Study
47%
Cross-Sectional Study
63%
Dabigatran
6%
Diabetes Mellitus
47%
Diabetic Complication
35%
Direct Oral Anticoagulant
47%
Doxorubicin
47%
Drug Absorption
47%
Drug Metabolizing Enzyme
23%
Gamma Glutamyltransferase
5%
Gastrointestinal Hemorrhage
8%
Hemoglobin A1c
23%
Infection
28%
Liver Disease
5%
Liver Enzyme
15%
Malignant Neoplasm
7%
Medication Error
34%
Memory Disorder
10%
Metformin
47%
Non Insulin Dependent Diabetes Mellitus
29%
Non-Steroidal Anti-Inflammatory Drug
8%
Nonalcoholic Fatty Liver
47%
Observational Study
6%
Pharmacodynamics
6%
Pharmacokinetic
30%
Polypharmacy
47%
Prevalence
13%
Rivaroxaban
6%
SARS Coronavirus
47%
Severe Acute Respiratory Syndrome
47%
Sodium Glucose Cotransporter 2 Inhibitor
47%
Therapeutic Window
23%
Warfarin
47%
Medicine and Dentistry
Adverse Event
9%
Amoxicillin
6%
Antiinfective Agent
47%
Antiulcer Agent
8%
Bariatric Surgery
95%
Clinical Research
7%
Cohort Analysis
5%
Cross Sectional Study
49%
Diseases
5%
Gastrointestinal Bleeding
20%
Gastroplasty
47%
Hazard Ratio
5%
Health Care
11%
Influenza Vaccine
47%
Laparoscopic Sleeve Gastrectomy
47%
Likert Scale
7%
Logistic Regression Analysis
11%
Medicare
5%
Medication Error
34%
Meta-Analysis
47%
Nonsteroid Antiinflammatory Agent
8%
Obesity Medicine
9%
Observational Study
5%
Patient Monitoring
5%
Pharmacodynamics
5%
Pharmacokinetic
5%
Prevalence
5%
Program Director
47%
Proportional Hazards Model
5%
Research Design
6%
Roux-en-Y
56%
Roux-en-Y Gastric Bypass
41%
Sleeve Gastrectomy
51%
Stress Ulcer
47%
Study Participant
5%
Nursing and Health Professions
Amoxicillin
7%
Antiinfective Agent
47%
Antimicrobial Stewardship
7%
Antiulcer Agent
8%
Chi Square Test
5%
Clavulanic Acid
7%
Clinical Pharmacy
47%
Confidence Interval
47%
Cross-Sectional Study
100%
Diabetes Mellitus
47%
Gastrointestinal Hemorrhage
8%
Healthcare System
7%
Hemoglobin A1c
9%
Logistic Regression Analysis
10%
Medication Error
39%
Non Insulin Dependent Diabetes Mellitus
9%
Nonsteroid Antiinflammatory Agent
8%
Odds Ratio
47%
Patient Compliance
47%
Polypharmacy
19%
Practice Guideline
7%
Primary Health Care
52%
Program Director
47%
Research Experience
7%
Socioeconomic Status
15%
Stress Ulcer
47%
Telemedicine
95%
